News - Catalyst Pharmaceutical

Filter

Current filters:

Catalyst Pharmaceutical

Popular Filters

Catalyst Pharma shares fall after mid-stage cocaine addiction trial delayed

27-09-2012

Catalyst Pharmaceutical Partners (Nasdaq: CPRX) shares fell 18.5% to $1.50 in premarket trading yesterday…

Catalyst PharmaceuticalCPP-109NeurologicalPharmaceuticalResearchVigabatrin Oral Solution

Back to top